Winner
Maintaining Adherence Programme
Summary of work
SEPT, a UK leader in the provision of mental health and community services, and Janssen, with its long heritage in psychiatry, came together to explore potential opportunities for joint working. Having identified shared values and strategic priorities they agreed to work together to test an innovative model of disease management in the UK that had the potential to significantly improve the pathway for people with schizophrenia, bipolar and affective disorders. This exciting undertaking placed digital innovation at the core, allowing aligned interests and shared values to deliver transformational innovation in healthcare provision and improved outcomes for patients. To date, MAP has delivered: outstanding patient, carer and staff experience/satisfaction results, considerable reduction in hospital admissions and significant improvements in efficiency/cost savings.
Judges’ comments
This was a focused initiative that tackled a massive issue in mental health. Through a well-executed, multi-faceted, multi-channel, patient programme implemented alongside the NHS, Janssen used an innovative approach which improved adherence, reduced exacerbations and admissions and produced real outcomes for the community.
